Mismatch Between Malaria Vaccines and Local Parasite Strains in Ethiopia
Release Date: 05/15/2025
EXTENDED: Baby Wraps and Malaria – A New Tool to Protect Young Children (with Ross Boyce)
Johns Hopkins Malaria Minute
In sub-Saharan Africa, mothers often carry their babies on their backs in colorful cotton wraps called lesu. Could treating these wraps with insecticide help prevent malaria? Dr. Ross Boyce discusses a groundbreaking study in Uganda showing that permethrin-treated wraps significantly reduce malaria in infants – and further, what this could mean for protecting the youngest and most vulnerable children from this often fatal disease.
info_outline
Insecticide-Treated Baby Wraps Cut Malaria Cases by Two-Thirds in Uganda
Johns Hopkins Malaria Minute
A new study in rural western Uganda finds that treating baby-carrying cloths, or lesu, with an insecticide with modest repellent effect significantly reduces malaria infections in young children. Transcript In many parts of sub-Saharan Africa, mothers carry their young children on their backs in colorful cotton wraps called lesu. Could treating these cloths with insecticide reduce malaria transmission? A study published in the New England Journal of Medicine explored this question in rural western Uganda, where malaria is transmitted year-round. Researchers enrolled 400 mothers with children...
info_outline
EXTENDED: Boosting Mosquito Immunity to Fight Malaria (with Emma Camacho)
Johns Hopkins Malaria Minute
Too much can kill the mosquito — too little can also kill it. But the right amount can strengthen the mosquito’s defenses and stop malaria transmission. Today, the Goldilocks dose. Emma Camacho shares how a natural compound called L-DOPA strengthens mosquitoes’ defenses at just the right concentration, revealing a new way to block malaria transmission.
info_outline
The Goldilocks Dose: Modulating Mosquito Diet to Control Malaria
Johns Hopkins Malaria Minute
Feeding mosquitoes L-DOPA can either strengthen their defences against malaria or shorten their lifespan — showing that in vector control, the dose makes the difference Transcript As with all medicine, the dose determines whether something helps or harms. Researchers recently looked at a substance commonly found in mosquito habitats that might form part of their diet. It’s called L-3-4-dihydroxyphenylalanine, or L-DOPA. Mosquitoes use it as a source of melanin. At low doses – up to a concentration of 2% – L-DOPA was toxic to mosquitoes and reduced the number of malaria parasites they...
info_outline
SPECIAL: Hackathons for Malaria Genetic Epidemiology (with Bryan Greenhouse)
Johns Hopkins Malaria Minute
How do you turn vast amounts of genetic data into actionable insight – efficiently and accurately? Professor Bryan Greenhouse of UCSF discusses a series of “hackathons” at the Johns Hopkins Malaria Research Institute (JHMRI) that bring together scientists from around the world to tackle one of the biggest challenges in malaria research: analyzing parasite genetics. By developing open-source tools, workflows, and training resources, these collaborations are making cutting-edge analysis more accessible to labs and public health programs everywhere.
info_outline
EXTENDED: From River Blindness to Malaria Control – The Ivermectin Story (with Carlos Chaccour and Joseph Mwangangi)
Johns Hopkins Malaria Minute
In Kwale, Kenya, where bed nets alone can’t stop malaria, researchers are testing ivermectin – a drug long used to treat parasitic infections – as a new way to kill mosquitoes. Trials show a 26% drop in malaria cases and added benefits against other mosquito-borne diseases, suggesting ivermectin could be a scalable, community-driven tool in the fight against insecticide resistance. With Carlos Chaccour (researcher at the Navarra Center for International Development) and Joseph Mwangangi (scientist at KEMRI) About The Podcast The Johns Hopkins Malaria Minute is produced by the Johns...
info_outline
Ivermectin’s Potential in the Fight Against Malaria
Johns Hopkins Malaria Minute
About The Podcast The Johns Hopkins Malaria Minute podcast is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
info_outline
EXTENDED: The Turning Point – What Drives Malaria to Become Severe? (with Mark Travassos, Mahamadou Ali Thera and Rafal Sobota)
Johns Hopkins Malaria Minute
Focusing on patients in Mali, researchers examine why some children develop life-threatening complications like cerebral malaria or severe malarial anemia. With Mark Travassos (University of Maryland School of Medicine), Mahamadou Ali Thera (University of Science Techniques and Technologies of Bamako), and Rafal Sobota (Northwestern University). About The Podcast The Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
info_outline
What Severe Malaria Cases Have In Common
Johns Hopkins Malaria Minute
Although severe malaria presents in different clinical forms – such as cerebral malaria or severe malarial anemia – a new study reveals that all severe cases have one thing in common: a shared inflammatory signature Transcript Whilst most cases of malaria are mild, some take a dangerous turn. In severe cases, the malaria parasite can overwhelm the body, disrupting the blood-brain barrier and leading to cerebral malaria, or destroying so many red blood cells that it triggers life-threatening anemia. Now, a new study has taken a closer look at this progression – from uncomplicated malaria...
info_outline
EXTENDED: Curing the Mosquito – Bed Nets That Target Parasites (with Alexandra Probst)
Johns Hopkins Malaria Minute
Dr. Alexandra Probst discusses a breakthrough in malaria prevention: bed nets coated with anti-parasitic drugs that stop transmission by curing infected mosquitoes. With Alexandra Probst, former graduate student at Harvard University. About The Podcast The Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
info_outlineA recent study in Ethiopia reveals that local malaria parasite strains differ genetically from those targeted by current vaccines, potentially reducing their effectiveness.
Transcript
The recent introduction of two malaria vaccines in sub-Saharan Africa represents a major success in global health, and the culmination of decades of research and development. The two jabs – RTS,S and R21 – target a protein on the surface of the malaria parasite as it enters the skin, called the circumsporozoite protein, or CSP. The vaccines are based on a specific form of CSP. The challenge is that there are many forms of CSP – called haplotypes – across regions. Vaccine efficacy, therefore, may in part depend on how closely local CSP haplotypes match those used to develop the vaccine. If they’re a close match, the vaccine should work well, but if there’s a mismatch, the vaccine may be less effective.
A recent study in Ethiopia collected blood samples from malaria-infected children over the age of five from three health centres in different parts of the country. Of the 120 blood samples collected, CSP was successfully sequenced in 85. Whilst there was little variation in samples from the same region, there was significant variation between regions, highlighting the genetic polymorphism of CSP. Importantly, none of the Ethiopian CSP haplotypes matched the vaccine haplotype, indicating the jabs may not achieve optimal efficacy in the country.
Source
Unveiling mismatch of RTS S AS01 and R21 Matrix M malaria vaccines haplotype among Ethiopian Plasmodium falciparum clinical isolates (Scientific Reports)
About The Podcast
The Johns Hopkins Malaria Minute podcast is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.